Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes

Wen Chin Ko, Chuang Ye Hong, Shaw Min Hou, Chien-Huang Lin, Eng Thiam Ong, Chwen Fang Lee, Chia Ti Tsai, Ling Ping Lai

研究成果: 雜誌貢獻文章同行評審

43 引文 斯高帕斯(Scopus)

摘要

Background: Atrial fibrosis is a feature of structural remodeling in atrial fibrillation (AF). Connective tissue growth factor (CTGF) is a potent profibrotic factor, but its role of CTGF in AF is not yet fully understood. Methods and Results: Right atrial appendages were obtained from 20 patients who underwent cardiac surgery (10 with sinus rhythm, 10 with AF). The mRNA level, protein level and immunohistochemical staining of CTGF were significantly increased in AF patients. In a porcine AF model, tissue angiotensin II (Ang II) and CTGF levels were significantly upregulated in both atria. In perfused rat hearts, Ang II stimulation increased CTGF expression, which could be inhibited by Ang II type I receptor antagonist. In a cell culture system, both atrial fibroblasts and myocytes were responsible for the increased CTGF expression under Ang II treatment. Ang II type I receptor antagonist could inhibit the Ang II-induced CTGF expression. Treating with recombinant CTGF, atrial fibroblasts expressed an increased level of collagen I. Furthermore, the CTGF level was highly correlated with tissue Ang II content in AF pigs. Conclusions: AF patients and animals exhibited a significantly increased expression of CTGF. Ang II stimulation upregulated CTGF expression in both atrial fibroblasts and myocytes. Ang II-induced CTGF expression might be involved in atrial substrate remodeling.
原文英語
頁(從 - 到)1592-1600
頁數9
期刊Circulation Journal
75
發行號7
DOIs
出版狀態已發佈 - 七月 2011

ASJC Scopus subject areas

  • 心臟病學與心血管醫學

指紋

深入研究「Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes」主題。共同形成了獨特的指紋。

引用此